Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-11-01

Clinical Trial Update: Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating inhibition of the renin-angiotensin system plus corticosteroids for proteinuria in IgA nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroids (corticosteroids)
  • Renin-Angiotensin System inhibitors (ACE inhibitors; Angiotensin II receptor blockers)

Snippet

Sponsor: Hospital Britanico | Conditions: IGA Nephropathy | Phase 4 | Status: COMPLETED